Select a community
All Communities
Home > Community Treatment Reports > Efavirenz-Emtricitabine-Tenofovir Treatment Report
What is Efavirenz-Emtricitabine-Tenofovir?

The antiretroviral drugs efavirenz, emtricitabine, and tenofovir are combined to be taken as one tablet once a day. It may be prescribed for use alone as a complete treatment option or in combination with other antiretroviral medications.

Side Effects

Side effects as an overall problem

Severe
13 13%
Moderate
20 19%
Mild
48 47%
None
22 21%

Most commonly reported side effects

Vivid dreams
57 71%
Dizziness
47 59%
Tiredness
35 44%
inconsistent sleep pattern
26 33%
Balance problems
15 19%
Rash/skin problems
13 16%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Efavirenz-Emtricitabine-Tenofovir. See all 20 dosages

  daily 1 daily 1 mg daily 1 tbs. daily 2 tbs. daily 10 g daily 200 mg daily 250 mg daily 300 mg daily 500 mg daily 600 daily 600 mg-200 mg-300 mg daily 600 mg daily 800 mg daily 1100 mg daily 1200 mg daily 2 x 600 mg-200 mg-300 mg daily 3 x 600 mg-200 mg-300 mg daily 30 x 600 mg-200 mg-300 mg daily 100 x 600 mg-200 mg-300 mg daily
  31 Number of Patients: 31 14 Number of Patients: 14 2 Number of Patients: 2 5 Number of Patients: 5 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 266 Number of Patients: 266 27 Number of Patients: 27 1 Number of Patients: 1 5 Number of Patients: 5 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Efavirenz-Emtricitabine-Tenofovir (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
24 60% Side effects too severe: 60%
Doctor's advice
9 23% Doctor's advice: 23%
Other
8 20% Other: 20%
Personal research
4 10% Personal research: 10%
Did not seem to work
1 3% Did not seem to work: 3%
Expense
1 3% Expense: 3%
Not indicated
1 3% Not indicated: 3%

See all 38 patients who’ve stopped taking Efavirenz-Emtricitabine-Tenofovir

Currently Taking Efavirenz-Emtricitabine-Tenofovir

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Efavirenz-Emtricitabine-Tenofovir

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
93 90%
Usually
8 8%
Sometimes
2 2%
Never
0 0%

Burden

Difficulty being on treatment

Very
7 7%
Somewhat
13 13%
A little
26 25%
Not at all
57 55%

Cost

Paid out of pocket

$200+
8 8%
$100-199
5 5%
$50-99
12 12%
$25-49
14 14%
< $25
42 41%

See more information, including instructions, precautions, side effects, and interactions.

Report created on March 18, 2010.